A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
A phase 2 trial of TQB2450, Anlotinib in non-small-cell lung cancer and small-cell lung cancer, run by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., now recruiting.
Overview
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer is a phase 2 interventional study registered as NCT05913089 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., with 58 participants planned, started 2023-06-14 and due to reach its primary completion in 2026-06. Interventions recorded: TQB2450 injection + Chemotherapy, TQB2450 injection + Anlotinib Hydrochloride Capsule. Conditions listed: Non Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
- TrialClinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialALTER 0303
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing), Non-small-cell lung cancer.
- TrialA Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
Shares Sino Biopharmaceutical (Chia Tai Tianqing), Small-cell lung cancer, Non-small-cell lung cancer.
- TrialAnlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialD-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standar
Shares Sino Biopharmaceutical (Chia Tai Tianqing), Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Can
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialA Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC
Shares Anlotinib, Non-small-cell lung cancer.